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GeneticsThe small Ras-like GTPase Rap1 is an evolutionary conserved protein that originally gained interest because
of its capacity to revert the morphological phenotype of Ras-transformed ﬁbroblasts. Rap1 is regulated by a
large number of stimuli that include growth factors and cytokines, but also physical force and osmotic stress.
Downstream of Rap1, a plethora of effector molecules has been proposed on the basis of biochemical studies.
Here, we present an overview of genetic studies on Rap1 in various model organisms and relate the observed
phenotypes to in vitro studies. The picture that emerges is one in which Rap1 is a versatile regulator of
morphogenesis, by regulating diverse processes that include establishment of cellular polarity, cell–matrix
interactions and cell–cell adhesion. Surprisingly, genetic experiments indicate that in the various model
organisms, Rap1 uses distinct effector molecules that impinge upon the actin cytoskeleton and adhesion
molecules.T. Zwartkruis).
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The small Ras-like GTPases form a protein family whose members
function as molecular switches regulating many signaling events that
control processes like proliferation, differentiation, morphogenesis
and apoptosis. In addition to the Ras proteins (H-, K-and N-Ras), this
family comprises Rap1, Rap2, R-Ras, TC21/R-Ras2, MRas/R-Ras3,
DexRas1/RasD1, RalA/B, Rheb, Rit, and the Rin proteins. The major
mode of regulation is via guanine nucleotide exchange factors (GEFs)
and GTPase activating proteins (GAPs). Together, they control GTPase
cycling between the active GTP-bound state and the inactive GDP-
bound state. GAPs enhance the intrinsic GTPase activity, resulting in
hydrolysis of GTP. Inducing the active conformation of GTPases by
GEFs results from enhanced release of bound GDP, allowing
association with GTP, which is more abundant in the cell (Bos et al.,
2007). The various GEFs most likely allow them to actively localize
GTP-loading to particular locations in the cell, which thereby result in
efﬁcient effector coupling. In addition, the sub-cellular localization
and phosphorylation status of a GTPase are factors that may
determine how they couple to downstream molecules.
H-, K-and N-Ras proteins are the best-studied members of this
family, in part because of their prominent role as oncogenes. Ras
proteins are found to be mutated in ∼15% of all human tumors (Bos,
1989). In addition, Ras also emerged in various genetic screens inmodel organisms, where signaling cascades have been delineated on
the basis of similar phenotypic traits. Perhaps the two most notable
examples are ommatidia development in the Drosophila eye and C.
elegans vulval development (e.g. (Nagaraj and Banerjee, 2004; Wang
and Sternberg, 2001)).
The subfamily of Rap proteins was cloned on the basis of homology
to Ras (Pizon et al., 1988) and gained interest on the basis of its
capacity to reverse the morphological transformation of ﬁbroblasts by
Ras (Kitayama et al., 1989). Although this effect of Rap1 over-
expression is still not fully understood, a great deal has been learned
from cell biological and biochemical experiments (for a recent review,
see Raaijmakers and Bos, 2008). In part, such experiments were
designed on the basis of genetic studies, especially in Drosophila.
Interestingly, the function of Rap1 has now been investigated by
genetic studies in at least some detail in virtually all model organisms.
Indeed, Rap1 has been highly conserved during evolution (Fig. 1).
Here, we present an overview of these genetic studies, where Rap1 or
its regulators have been disrupted and discuss how the results
obtained by genetic approaches relate to in vitro studies. We will also
describe genetic evidence that links candidate effectors to Rap1.
The small Ras-like GTPase Rap1
Nowadays, the mammalian Rap proteins Rap1A and Rap1B are
generally regarded to act independently of Ras. Functions attributed
to Rap1 comprise the control of establishment of cell polarity
(Schwamborn and Puschel, 2004; Shimonaka et al., 2003), activation
of integrin-mediated cell adhesion (Caron et al., 2000; Katagiri et al.,
2000; Reedquist et al., 2000; Tsukamoto et al., 1999) and the
Fig. 1. ClustalX alignment of protein sequences from those species discussed in this review that are most highly related to human Rap1A.
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Additionally, Rap1 has been implicated in cell proliferation (Altschu-
ler and Ribeiro-Neto, 1998) and secretion (Crittenden et al., 2004;
D'Silva et al., 1998). Biochemical approaches to measure GTP-loading
of Rap1 by GEFs have provided clear evidence for the existence of at
least ﬁve distinct classes of GEFs: C3G (RapGEF1), PDZ-GEF1 and-2
(RapGEf2 and 6), Epac1,-2 and Repac (RapGEF3, 4 and 5), CalDAG-
GEF1 (RasGRP2) and Dock4 (reviewed in Pannekoek et al., 2009; see
van Dam et al., 2009, for evolutionary aspects). The activity of many of
these GEFs has been demonstrated in overexpression studies and/or
more directly by in vitro GEF assays using puriﬁed proteins. It should
be kept in mind though, that many of these GEFs are not entirely
Rap1-speciﬁc, but can activate other GTPases like Rap2 isoforms as
well. The same holds true for the negative regulators of Rap1 like
Rap1GAPI and-II, Spa1 and SIPA1L1/E6TP1. Almost all candidate
effector molecules described for Rap1 to date have initially been
isolated on the basis of their binding to GTP-bound Rap1. Again, these
effectors may also interact with other Ras-like GTPases, which
complicates our understanding of the speciﬁcity of GTPases signaling.
Genetic studies in model organisms can help to resolve questions
about the in vivo speciﬁcity of GEFs, GAPs and effectors. More
importantly, they can disclose physiological processes in which the
Rap1 signaling pathway operates.
Saccharomyces cerevisiae
In the budding yeast S. cerevisiae establishment of the bud-site, the
site where the daughter cell will grow and separate, reveals the
polarized organization of the mother cell. The position of the new
bud-site is located either at the same side as the previous bud-site or
on the opposite side of the cell. After bud-site selection, proteins are
recruited for the formation of the bud and the actin cytoskeleton is
organized in the direction of the new bud to allow growth. Loss of the
single homologue of Rap1 in S. cerevisiae, Bud1p/Rsr1p (59% identity,
79% similarity with Rap1A), leads to randomized localization of the
bud-site (Cabib et al., 1998; Chant and Herskowitz, 1991). When
compared to Rap1, Bud1p has a long C-terminal insertion. This
fragment, however, seems not essential for bud site selection
(Michelitch and Chant, 1996). Strikingly, also loss of proteins with
Bud1p/Rsr1p GEF and GAP activity, Bud5 and Bud2 respectively, leads
to random bud-site formation (Bender and Pringle, 1989; Park et al.,
1993). This strongly suggests that cycling is important for Bud1
function. Bud-site assembly requires the recruitment of Cdc24p, an
exchange factor for the GTPase Cdc42p that binds to GTP-bound
Bud1p/Rsr1p. In addition, the scaffold protein Bem1p binds to Cdc24p
and to Bud1p/Rsr1p in a GDP-dependent manner and thereby
presumably regulates the formation of a complex consisting of
Bud1p/Rsr1p and Cdc24p to regulate Cdc42p activity (Park et al.,
1997). Thus, in this unicellular organism, activation of Bud1p/Rsr1p is
required for positioning the bud site by cell-internal polarity cues by
regulating the actin cytoskeleton via a single effector, Cdc24p. There
are indications that this function of Bud1/Rsr1p has been conserved
during evolution. First, in tissue culture experiments Rap1 has been
found to be involved in the establishment of polarity. For instance, in
lymphocytes Rap1 is pivotal for chemokine-induced cell polarization
characterized by formation of a leading edge and uropod, which both
contain a unique set of marker proteins (Shimonaka et al., 2003).
Secondly, in hippocampal neurons, Rap1 functions in axon-fate
determination (Schwamborn and Puschel, 2004). In both cases,
Rap1 seems to function upstream of Cdc42 and to localize and
activate the polarity-establishing Par-complex (Gerard et al., 2007;
Schwamborn and Puschel, 2004). How Rap1 induces GTP-loading of
CDC42 in mammalian cells has not been elucidated, but this may be
via direct binding of a CDC42 GEF. Binding of GTP-bound Rap1 to at
least two distinct Rho-family GEFs has been reported. In the case of T-
cells, Rap1 has been shown to directly bind to the Rac-GEF Tiam1,which also binds to Par3. However, this interaction was suggested to
lead to Rac1 activation downstream of CDC42 activity (Gerard et al.,
2007). In a separate study, Rap1 has been shown to bind to Vav2
(Arthur et al., 2004), the closest mammalian homologue of the
budding yeast protein Cdc24p. This interaction leads to Rac-
dependent cell spreading rather than establishment of cellular
polarity. It is striking that the binding site of Rap1 on these exchange
factors has been reported to reside in the catalytic domain, whereas
the binding site for Bud1 has been suggested to be either at the C-
(Park et al., 1997) or at the N-terminus (Gulli and Peter, 2001) of
CDC24. Taken together, Bud1/CDC24/CDC42 cannot simply be
regarded as an evolutionary conserved signaling module. However,
it may be derived from an ancestral cascade that linked Ras-like
GTPases to Rho-like GTPases and which in vertebrates may have
evolved into pathways like Rap1/Vav2/Rac and Rap1/RhoGEF(?)/
CDC42.
Dictyostelium discoideum
In the unicellular amoeba D. discoideum, Rap1 is presumably an
essential gene since no knock-out cells have been obtained (Kortholt
et al., 2006). Possibly, such mutants are inviable due to the fact that
morphogenetic events in D. discoideum are more dynamic as
compared to yeast. For example, D. discoideum can rapidly respond
to chemical signals from its environment by chemotaxis and is able
to form multi-cellular aggregates. Functions that have been
attributed to Rap1 include the control of cell polarity, cell adhesion,
endocytosis, phagocytosis and osmotic stress resistance (Chubb and
Insall, 2001; Kortholt and van Haastert, 2008; Rebstein et al., 1997;
Seastone et al., 1999). Thus far, three regulators of Rap1 have been
characterized, the GEF GbpD (Kortholt et al., 2006) and the GAPs
RAPGAP1 (Jeon et al., 2007a) and RapGAPB (Parkinson et al., 2009).
Overexpression of active Rap1 induces a more spread and ﬂat
cellular phenotype with more peripheral F-actin. These cells adhere
more strongly to the extra-cellular matrix and display a substantially
decreased chemotaxis (Jeon et al., 2007b; Kortholt et al., 2006;
Rebstein et al., 1993). This phenotype is mimicked in cells
overexpressing GbpD (Kortholt et al., 2006). In contrast, GbpD-
deﬁcient cells are hyperpolar, extend fewer lateral pseudopods but
show normal remodeling of the actin cytoskeleton at the leading
edge. In one study, increased adhesion seen upon GpbD over-
expression was found to depend on the presence of Phg2. Phg2 is a
serine/threonine kinase that speciﬁcally interacts with GTP-bound
Rap1 via its Ras association (RA) domain and loss of Phg2 resulted in
diminished cell adhesion (Kortholt et al., 2006). Formation of lateral
pseudopods and decreased polarity, however, were found to be Phg2
independent, suggesting the existence of an additional Rap1 effector.
In a more recent study, Phg2 was shown to colocalize with active
Rap1 at the leading edge of migrating D. discoideum cells. Although
Phg2 localization was independent of the RA domain and thus of
Rap1 binding, the RA domain was required for Phg2 activity. Phg2
was found to induce MyoII phosphorylation, leading edge MyoII
disassembly, decreased cortical tension and enhanced protrusive
activity at the leading edge. Remarkably, however, in this latter
study it was found that Phg2 negative cells have increased cell
attachment, which may be due to different assay conditions or stem
from the use of a distinct parental wild-type strain (Kortholt et al.,
2006) (Jeon et al., 2007a). Loss of RapGAPB leads to enhanced Rap-
GTP levels and a concomitant increase in cell–matrix adhesion.
While chemotaxis toward cAMP is not affected, RapGAPB negative
cells are severely impaired in formation of multi-cellular aggregates,
most likely as a consequence of altered cell–cell adhesion. In
summary, studies in D. discoideum highlight a prominent role for
Rap1 in processes like cell adhesion, polarity and migration. Rap1
mediates its effects at least in part via activation of the Phg2 kinase,
for which in multi-cellular organisms unfortunately no clear
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role in phosphorylation of MyoII has not well been investigated yet.
Drosophila melanogaster
Studies on the function of Rap1 in Drosophila have been crucial for
elucidation of its role in cell migration and adherens junction
formation. Rap1 is an essential gene in Drosophila: homozygous
Rap1 null mutants die during larval stages while depletion of
maternal input causes embryonic lethality. These embryos show
various morphogenetic and migration defects described below (Asha
et al., 1999). Importantly, none of the observed phenotypes appears to
be caused by defects in cell proliferation or speciﬁcation. Adult ﬂies do
not depend on Rap1 for viability although mutant female ﬂies stop
producing progeny due to degeneration of the egg chambers. Three
morphogenetic events involving cell sheets are affected in embryos
devoid of Rap1. These are ventral furrow closure, dorsal closure and
head involution. In addition, migration of individual mesodermal and
pole cells is defective.
The defects in ventral furrow closure in Rap1-deﬁcient embryos
most likely result from the inability of ventral cells to reorganize their
actin cytoskeleton in a coordinated fashion. Ventral furrow formation
is initiated by apical constriction of the actin-myosin network in
mesectodermal cells (Martin et al., 2009). This process starts normally
in mutant embryos, but cells fail to come together at the midline,
especially in anterior regions. In cross sections, cells appear
abnormally shaped and their nuclei, which move basally in wild-
type animals, are found at different positions along the apico-basal
axis. The Rap1 effector involved in this process is unknown.
Dorsal closure depends on the dorsalward migration of lateral
epithelial cells, which elongate along the dorsal-ventral axis, over a
structure that is named amnioserosa. The lateral epithelia meet at the
dorsal midline to entirely cover the embryo (reviewed in Jacinto et al.,
2002). Dorsal closure requires activation of the JNK-pathway that
leads to expression of the TGF-β-like DPP protein in leading edge cells.
Simultaneously, actin-based ﬁlopodial and lamellar protrusions are
formed on the dorsal side of these cells. Defective dorsal closure, as
seen in Rap1-negative embryos, can be mimicked by expression of
dominant negative Rap1N17 in lateral ectoderm and resembles the
phenotype of Canoe (Cno) mutant embryos (Boettner et al., 2003).
Cno is an adaptor protein that can interact with GTP-bound Rap1 via
its N-terminal RA-domains. Both proteins co-localize with DE-
cadherin in adherens junctions but the localization of Cno does not
depend on the interaction with Rap1. Intriguingly, overexpression of
wild-type Cno suppresses dorsal closure defects induced by Rap1N17,
but a Cno isoform that lacks the RA-domains does not. This latter
isoform has retained signiﬁcant activity since it can suppress a Cno
loss of function phenotype via activation of the JNK-pathway.
Together, these studies indicate that Cno fulﬁlls a Rap1-dependent
and a separate, JNK-dependent function in dorsal closure. Boettner
and colleagues also demonstrated that the PDZ-GEF homologue dPDZ-
GEF (also known as Dizzy or Gef26) functions upstream of Rap1 in this
process: dPDZ-GEF loss-of-function mutants have dorsal closure
defects and hypomorphic alleles show profound genetic interactions
with Rap1 and Cno. How do mutations of genes, encoding proteins
that localize to the lateral membrane, interfere with dorsal closure?
The failure of epithelial cells to stretch in a dorso-ventral direction as
seen in all three mutants, hints at a diminished contractility of the
actin cytoskeleton. Indeed, the non-musclemyosinMyoII (encoded by
zipper) fails to assemble into a continuous cable at the leading edge of
the lateral epithelium in these mutants. Possibly, this actin network is
connected to adherens junctions where dPDZ-GEF, Rap1 and Cno
reside. Furthermore, dPDZ-GEF mutant cells generated during wing
development have an increased circumferential size and a less
compact MyoII network, suggesting that dPDZGEF may indeed affect
MyoII function (Boettner and Van Aelst, 2007).It should be noted that in all situations described above, adherens
junctions have an intact appearance. This is in contrast with the
situation in clones of Rap1 mutant cells in the wing. Here, adherens
junctions do not encircle epithelial cells, but instead are condensed to
one side. The composition of these aberrant adherens junctions
appears normal as shown by the presence of DE-cadherin, α-catenin,
β-catenin and Cno. In addition, their location along the apicobasal axis
is unchanged. An interesting model was proposed where Rap1 is
required to reseal the adherens junctions after cell division and does
so via counteracting tension-generating components from the
unclosed adherens junction (Knox and Brown, 2002). In contrast to
wild-type mitotic lineages that usually remain in coherent group,
Rap1 deﬁcient wing cells have an aberrant cell shape and disperse into
the surrounding wild-type tissue. Since the adherens junction
phenotype is observed ahead of dispersion of mutant cells into
wild-type clones, this sorting phenotype appears to be the conse-
quence rather than the cause of abnormal adherens junctions. Loss of
adherens junctions from a particular side of a cell has also been seen in
the testis of dPDZ-GEF mutant ﬂies (Wang et al., 2006). Here,
continued proliferation of germ stem cells (GCS) critically depends on
their attachment to a group of somatic cells, called the hub. In dPDZ-
GEF mutant males, DE-cadherin is strongly diminished at the GCS/
hub interface but appears normal between hub cells. As a conse-
quence, GCS loose contact with hub cells and cannot maintain their
stem cell identity (Wang et al., 2006).
In vertebrate tissue culture cells, a function for Rap1 in cadherin-
mediated cell–cell adhesion has been demonstrated, but an uneven
distribution of adherens junctions around the circumference of cells
has not been mimicked. Blocking Rap1 in MDCK cells interferes in
homotypic E-cadherin interactions (Price et al., 2004) and interferes
in the recruitment of E-cadherin to nascent junctions in MCF7 cells
(Hogan et al., 2004). In this latter study, CDC42 was postulated as a
downstream effector of Rap1, in part based on the observation that an
active isoform of CDC42 could overcome the inhibition of Rap1 in
junction formation. It remains to be established how direct this effect
is. In another study, the homologue of Cno, Afadin (also known as
Af6), was suggested to be a critical Rap1 effector in cadherin
regulation. Using a cell free assay, Hoshino et al. (2005) found that
Afadin inhibits endocytosis of E-cadherin molecules that are not
ligated to E-cadherin on neighboring cells. Interestingly, knock down
of PDZ-GEF2 in A549 lung carcinoma cells did not drastically diminish
E-cadherin levels at the cell surface, but increased the fraction of
immature junctions (Dube et al., 2008). Immature junctions can be
recognized by their zipper-like appearance upon staining for
junctional proteins. Maturation into linear cell–cell junctions requires
remodeling of the actin cytoskeleton (Mege et al., 2006), possibly via
Myosin VI (Maddugoda et al., 2007). Thus, as seen for integrins
(described below), Rap1 may play a role in the connection between
cell surface adhesion molecules and the cytoskeleton, which are
involved in complex interdependent interactions.
Loss of dPDZ-GEF also affects the shape and migration of
macrophages in Drosophila. This effect results from the inability of
Rap1 to regulate integrins (Huelsmann et al., 2006), but the nature of
the downstream Rap1 effector here is elusive. Whether diminished
integrin function also underlies the above-mentioned abnormal
migration of mesectodermal and pole cells in Rap1 mutant embryos
is currently unknown. Effects of Rap1 on integrins had already been
demonstrated in various tissue culture cell lines (Caron et al., 2000;
Katagiri et al., 2000; Reedquist et al., 2000) and will be discussed in
more detail in the section on the function of Rap1 in mice.
Apart from Cno, two other effectors, namely D-raf (Lee et al., 2002;
Mishra et al., 2005) and the RalGEF Rgl1 (Mirey et al., 2003) have been
postulated to function downstream of Rap1 in Drosophila. Direct
binding to GTP-bound Rap1 has been demonstrated both for D-raf and
Rgl1. D-raf as well as dMEK and dMAPK were found to suppress a
rough eye-phenotype induced by overexpression of dPDZ-GEF (Lee et
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enhance signaling via the above-mentioned elements of the MAPK
pathway had a similar effect. Rap1 and D-raf have also been
implicated in differentiation of terminal structures, downstream of
the torso tyrosine receptor (Mishra et al., 2005). The idea that Rgl1
functions downstream of Rap1 is based on suppression of larval and
eye-speciﬁc phenotypes induced by activated Rap1, that is seen upon
lowering Rgl1 activity or expression of dominant negative Ral. The
simplest explanation is that Rgl1 functions as a direct Rap1 effector.
However, the authors keep the option open that Ral operates in a
parallel pathway, required for effective Rap1 signaling (Mirey et al.,
2003). This would be more similar to the situation in vertebrates.
Here, Rap1 can bind with high afﬁnity to various RalGEFs but no direct
evidence has been presented that this leads to activation of the latter.
For example, stimuli like cAMP analogues that increase the fraction of
GTP bound Rap1 leave Ral-GTP levels unaffected (Zwartkruis et al.,
1998).
Loss of RapGAP1, the closest homologue of human Rap1GAP does
not result in any obvious phenotype, suggesting that it functions in a
redundant fashion with another Rap1GAP encoded in the Drosophila
genome (Chen et al., 1997).
Caenorhabditis elegans
In contrast to Drosophila, rap-1 deﬁcient worms are viable and
fertile. During larval stages, the related RAP-2 (a clear homologue of
mammalian Rap2) may compensate for the loss of RAP-1. A large
fraction of rap-1;rap-2 homozygous animals die as scrawny animals,
unable to complete the molting processes that take place at the
transition of the four larval stages (Frische et al., 2007). Their
phenotype is very similar to that of null mutants of pxf-1, which
encodes the C. elegans homologue of PDZGEF and activator of Rap1
and Rap2 (Pellis-van Berkel et al., 2005). Electron microscopy of pxf-1
mutants reveals that their cuticles are abnormal. This is indicative for
compromised secretion at the apical side of the outer epithelium of
the worm, which is referred to as hypodermis. It is presently unclear if
this results from hypodermal polarity defects or an impairment of the
secretion process.
Although RAP-1 deﬁcient embryos develop normally, they are
highly sensitive to a decreased activity of RAL-1. RNAi for the RAL-1
effectors EXOC-8 and SEC-5 also results in embryonic lethality, while
this does not affect wild-type embryos (Frische et al., 2007). In all
cases, the stereotypical rows of hypodermal cells, which arise at the
dorsal side of the embryo and move toward the ventral side to
envelope the embryo in wild-type animals, are completely disorga-
nized. Furthermore, the hypodermal cells in such embryos are
hallmarked by the absence of the α-catenin homologue HMP-1
from adherens junctions. In contrast, the localization of the slightly
more basally located DLG-1 protein is unaffected. A role for the Ral/
exocyst pathway in targeting E-cadherin to the lateral membrane had
already been proposed on the basis of studies in Drosophila (Classen et
al., 2005; Langevin et al., 2005) and vertebrate (Shipitsin and Feig,
2004) cells. Most likely, in the absence of RAP-1, a proper balance
between membrane targeting of the cadherin HMR-1 and its
internalization cannot be maintained in the developing embryonic
hypodermis when RAL-1 signaling is diminished. However, the
molecular mechanisms by which RAP-1 exerts its function remain
to be identiﬁed.
Lower vertebrates: Xenopus laevis and Danio rerio
Although themorphogenetic processes, in which Rap1 functions in
ﬂies and worms are well studied, the exact signaling pathways that
regulate Rap1 are poorly deﬁned. Interestingly, in X. laevis Rap1 was
identiﬁed as a component of the non-canonical Wnt pathway (Tsai et
al., 2007). This pathway is required for convergence extension (CE)movements during gastrulation. CE is a process that depends on
localized cell traction, shape changes and migration and results in the
transformation of a broad plate of dorsal mesoderm and neurecto-
dermal cells into a more elongated structure (for a review, see
Solnica-Krezel, 2005). Wnt8 signaling leads to activation of Casein
Kinase I ɛ (CKIɛ), a protein that can bind to and phosphorylate the
RapGAP SIPA1L1/E6TP1. As a consequence, SIPA1L1/E6TP1 is desta-
bilized and an increase in GTP-bound Rap1 levels is seen. Interfering
with Rap1 signaling in Xenopus embryos by injection of a CKIɛ-
resistant isoform of SIPA1L1/E6TP1, dominant negative Rap1 or
antisense Rap1A/B morpholino oligonucleotides leads to defects in
CE. The resulting embryos show defects in the closure of the
blastopore and have a short and bended body axis. No defects were
observed in β-catenin-induced axis formation. A similar role for Rap1
was described in zebraﬁsh (Tsai et al., 2007).
Rap1 has also been invoked in hingepoint formation during neural
tube closure in X. laevis (Haigo et al., 2003). Hingepoints are formed
by only a few cells of the neural plate that aremarked by expression of
the actin-binding protein Shroom. In these neural cells, Shroom
protein is required for apical constriction, a process most likely
mediated by the actin network. Shroom expression has a very similar
effect in polarized cultured MDCK cells, but appears inactive in non-
polarized cells of the Xenopus embryo. Dominant negative Rap1N17
and Rap1GAP expression block apical constriction and result in
defective neural closure. The exact role of Rap1 in this process or its
downstream effector has not been identiﬁed.
Rap1 has not yet been extensively studied in zebraﬁsh, but two
proteins have been proposed to act as Rap1 effectors here. First, a
Cno/Af6-related gene product named Radil was shown to be required
for migration of neural crest cells (Smolen et al., 2007). Evidence that
this protein functions as a Rap1 effector is mostly based on the speciﬁc
interaction with GTP-bound Rap1. It will therefore be interesting to
see if also genetic data can be obtained that sustain a role for Rap1
itself in neural crest cell migration. Secondly, the homologue of KRIT1
(Krev interactor 1)/CCM1 (cerebral cavernous malformation 1) may
function downstream of Rap1 in zebraﬁsh in endothelial junction
formation (Gore et al., 2008). Although this study nicely shows
synthetic RNAi effects for Rap1 and KRIT1/CCM, they do not form a
solid base for epistasis analysis and this putative effector will be dealt
with in the section on mouse.
Mus musculus
Rap1 and integrins
The mouse genome encodes two Rap1 genes, Rap1A and Rap1B,
which differ by only nine amino acids and are both highly conserved
in mammals. Two independent Rap1A−/− mouse strains have been
generated and these appear viable and fertile (Duchniewicz et al.,
2006; Li et al., 2007). Despite the fact that the immune system is
functional and no major abnormalities in the various hematopoietic
compartments were detected, isolated Rap1A-deﬁcient cells display a
number of anomalities. For example, spleen cells adhere less
efﬁciently to ﬁbronectin or ICAM. The differential adhesion was not
due to a difference in the level of cell surface expression of the
corresponding receptors (VLA-4 and LFA-1, respectively), suggesting
that the process of integrin activation is affected. Furthermore,
polarization of LFA-1 in T-cells following CD3 treatment was mildly
affected (Duchniewicz et al., 2006). Adhesion of macrophages was
also impaired, while random movement of these cells (haptotaxis)
was enhanced, possibly as a consequence of less restrained detach-
ment from the extra-cellular matrix. In contrast, directed cell
migration of e.g. splenic B and T cells toward chemokines like CCL21
was reduced. Macrophages ingested IgG-coated red blood cells more
efﬁciently, even though they possessed similar numbers of Fc-gamma
receptors as their wild-type counterparts (Li et al., 2007). The
relatively mild phenotype of Rap1A knock-out mice may result from
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presence has been demonstrated in a number of Rap1A-negative
cell types described above. Indeed, B-cells from Rap1B null mutant
animals also show adhesion defects to ICAM-1, showing that both
Rap1 isoforms can perform similar functions (Chu et al., 2008). Taken
together, studies with knock-out mice conﬁrm a role for Rap1 in
activation of integrins as had previously been described in tissue
culture cells (Caron et al., 2000; Katagiri et al., 2000; Reedquist et al.,
2000; Tsukamoto et al., 1999) and in transgenic mice expressing a
constitutively active Rap1A-V12 in T-cells. In this latter model, T-cells
bind more strongly to ﬁbronectin and ICAM-1 via avidity modulation
of β1 and β2 integrins (Sebzda et al., 2002). Loss of Rap1B also
interferes in αIIbβ3 integrin activation in platelets, where Rap1B is the
predominantly expressed isoform. Platelets from Rap1B-deﬁcient
mice aggregate less well under the inﬂuence of various agonists and
show diminished binding of soluble ﬁbronectin to αIIbβ3 integrin, a
direct measure for its activation state. In addition, a delay in the
characteristic shape change of platelets was observed for all tested
agonists and cell spreading on ﬁbronectin was compromised
(Chrzanowska-Wodnicka et al., 2005). An integrin activation defect
is also seen in platelets of mice mutant for the calcium and
diacylglycerol responsive Rap-1 GEF CalDAG-GEF1 (RasGRP2) (Crit-
tenden et al., 2004). This is in line with the ﬁnding that Ca+ and
diacylglycerol lead to GTP-loading of Rap1 in human platelets (Franke
et al., 1997). In other cell types or under the inﬂuence of other stimuli,
Rap1-GEFs distinct from CalDAG-GEF1 appear crucial for integrin
activation. PDZ-GEF2 is involved in TNFα-induced integrin activation
in splenocytes (Yoshikawa et al., 2007), while C3G has a stimulatory
effect on cell adhesion on collagen and ﬁbronectin in mouse
embryonic ﬁbroblasts (Ohba et al., 2001).
How do Rap1 proteins mediate inside-out activation of integrins?
Clearly, the integrin binding protein talin is essential for activation of
integrins and appears to act together with kindlins (Larjava et al.,
2008). Interestingly, Rap1 appears to be capable of activating a variety
of integrins in many cell types with the notable exception of α6β4
integrin, that is not coupled to the actin cytoskeleton (Enserink et al.,
2004). In T-cells and dendritic cells, the Rap1 effector RapL and its
splice isoform Nore1 (Rassf5) appear to play a crucial role (Katagiri et
al., 2003). GTP-bound Rap1 induces complex formation of RapL with
LFA-1 (αLβ2), thereby changing its afﬁnity and spatial distribution.
RapL is also present in platelets, where it may play an analogous role
(Crittenden et al., 2004). Themechanism appears to involve activation
of the RapL-bound kinase MST1 (Katagiri et al., 2006). However, RapL
is absent from many other cell types that form integrin-mediated
contacts with the ECM. In these cells, Rap1 may mediate its action via
another effector, named RIAM (Lafuente et al., 2004). This adaptor
protein is located at the leading edge of lamellipodia, where it
interacts with actin-reorganizing proteins like proﬁling and Ena/
VASP. Overexpression of RIAM induces cell spreading in HEK293 and
Jurkat T-cells, whereas reduction of RIAM expression decreases
cellular F-actin in Jurkat T-cells. Furthermore, RIAM overexpression
was also found to enhance β1 and β2 integrin-mediated adhesion to
ﬁbronectin, although the molecular mechanism has not been resolved
(Lafuente et al., 2004). Using a CHO model system, Han et al. (2006)
demonstrated that Rap1-induced complex formation of RIAM and
talin unmasks an integrin binding site in talin for the cytoplasmic tail
of αIIbβ3 integrins. It will be interesting to see if genetic disruption of
RIAM causes hemostasis defects, similar to that of Rap1B−/− mice or
perhaps an even stronger phenotype due to general malfunctioning of
integrins.
Rap1 and the vasculature
While the hemostasis phenotype described above for Rap1B
mutant animals is not lethal, a bleeding phenotype results in 85%
embryonic and perinatal lethality in this strain (Chrzanowska-
Wodnicka et al., 2005). Since platelets are not required for embryonichemostasis, the bleeding phenotype most likely results from a
defective vasculature. Indeed, postnatal neovascularization of the
retina is delayed in Rap1B mutant animals and microvessel sprouting
from aortic rings in vitro under the inﬂuence of VEGF is impaired
(Chrzanowska-Wodnicka et al., 2008). This may be caused by a
combination of the observed decreased proliferation and migration of
endothelial cells, but a role for smooth muscle cells cannot be
excluded. Staining of adherens junctions for the major cadherin
isoform in endothelial cells, VE-cadherin, did not reveal any obvious
abnormalities. At the molecular level, activation of p38 MAPK by bFGF
and VEGF was attenuated in Rap1B mutant endothelial cells
(Chrzanowska-Wodnicka et al., 2008). Very similar effects, including
impaired FGF2 induced angiogenesis and endothelial cell migration
have been found in Rap1A mutant mice (Yan et al., 2008). Also
ischemia-induced neovascularization was reduced in Rap1A mutant
mice as demonstrated in an neovascularization assay (Carmona et al.,
2009).
Mouse embryos homozygous mutant for PDZ-GEF1 provide
additional evidence for a vascular function of Rap1. The primary
defect in these animals is formation of the vasculature of the yolk sac:
blood islands form normally, but fail to fuse and generate a plexus of
vascular channels. Also intra-embryonic vasculogenesis is affected,
but this might be a secondary defect resulting from the inability of the
yolk sac to supply the embryo with nutrients. As a consequence, PDZ-
GEF1−/−embryos die around embryonic day 10 (E10) (Wei et al.,
2007). Hypomorphic C3G mutant embryos die slightly later in utero
with pronounced hemorrhage in neural tissues (Voss et al., 2003).
Remarkably, in these embryos defective recruitment and/or adhesion
of smooth muscle cells that support endothelial cells, was observed.
Although the authors suggest that abnormal smooth muscle cells are
causative for the phenotype, the primary defect may reside in
endothelial cells. For example, in case of cerebral cavernous
malformation (CCM) hemorrhages in neural tissues are also associ-
ated with endothelial cells lacking smooth muscle support and a
mouse model system for this disease has established that an
endothelial cell-autonomous effect underlies the lack of supporting
cells (Whitehead et al., 2009). Another hallmark of CCM (not reported
in C3G or Rap1 mutants) are thin-walled endothelial cells that
encompass enlarged vascular structures. CCM results from autosomal
dominant mutations in one of three genes, named CCM1/KRIT1,
CCM2/OSM and CCM3/PCDC10. The proteins encoded by these genes
can form a complex and CCM1 has been found to interact with GTP-
bound Rap1 (Serebriiskii et al., 1999). Using in vitro cultured
endothelial cells, Rap1 was found to increase the localization of
CCM1/KRIT1 to adherens junctions and stimulate its interaction with
junctional proteins like β-catenin and Af-6 (Glading et al., 2007).
Conversely, knock down of CCM1/KRIT1 resulted in a disruption of β-
catenin localization to adherens junctions and an increase in the
permeability of the endothelial cell layer for horse radish peroxidase.
Although this appears to be in line with a paucity of endothelial
junctions in CCM patients as revealed by EM studies (Clatterbuck et
al., 2001), it should be kept in mind that that study revealed many
other ultra-structural changes, like the above mentioned lack of
supporting cells, a thick collageneous matrix without intervening
neural tissues and hemosiderin deposits. In addition, such an analysis
in CCM1-and CCM2-deﬁcient zebraﬁsh showed that the thin-walled
endothelial cells surrounding dilated vessels contained normal
adherens junctions (Hogan et al., 2008). KRIT1 RNAi also drastically
changes the cortical actin cytoskeleton into one with prominent stress
ﬁbers. A very similar phenotype is seen upon CCM2 knock down,
which has been linked to activation of Rho (Whitehead et al., 2009). A
reverse, albeit less dramatic effect is seen when Rap1 is activated in
human umbilical vein endothelial cells using the Epac1-speciﬁc
compound 8-CPT-2′O-Me-cAMP (Kooistra et al., 2005). Since this
was also seen in sparse cell cultures, it is unlikely to result fromKRIT1-
mediated junctional strengthening.
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Rap1 performs various functions in the vasculature of vertebrates.
They may include regulation of cell–cell contacts and modulation of
the cytoskeleton via CCM proteins. However, additional studies to
more precisely deﬁne the vascular phenotypes are required to clarify
how they relate to those observed in the absence of CCM-proteins,
ﬁbronectin or VE-Cadherin (George et al., 1997; Gory-Faure et al.,
1999).
Rap1 in tumorigenesis
The ﬁrst indication that Rap1 may be involved in tumorigenesis,
independently of Ras, came from studies where Rap1B was expressed
in Swiss 3T3 cells and injection of these cells in nude mice resulted in
the formation of solid tumors, without any signs of metastasis
(Altschuler and Ribeiro-Neto, 1998). Additional evidence for a role of
Rap1 in tumorigenesis came from studies on Rap-GEFs and Rap-GAPs.
In BHX-2 acute myeloid leukemic cells, the exchange factor CalDAG-
GEF1 is activated leading to enhanced proliferation andmorphological
transformation (Dupuy et al., 2001). Deletion of SIPA1/SPA1 leads to
expansion of bone marrow-derived pluripotential hematopoietic
progenitors and chronic myelogenous leukemia in mice (Ishida et
al., 2003). In line with this, overexpression of Rap1GAP has been
reported to reduce squamous cell carcinoma growth (Zhang et al.,
2006). SIPA1L1/E6TP1, a GAP for Rap1 has been identiﬁed as a target
of the HPV E6 oncoprotein that mediates ubiquitin-dependent
degradation leading to enhanced Rap1 activation and cellular
transformation (Gao et al., 1999; Singh et al., 2003). Together these
studies indicate that overactive Rap1 can enhance the proliferative
capacity of certain cell types. However, it is important to note that
Rap1 may also prevent tumorigenesis by counteracting metastatic
processes. In prostate and ovarian cancer, mutations in an atypical
Rap-GEF named Dock4, result in compromised Rap1-activation.
Osteosarcoma cells, lacking functional Dock4, fail to form adherens
junctions and show enhanced tumor invasion. Expression of Dock4 or
Rap1E63 in these cells reverses the phenotype (Yajnik et al., 2003).
Similarly, SIPA1/SPA1 was identiﬁed as modiﬁer of metastasis
efﬁciency: a mutant allele enhances the invasive potential of breast
cancer cells to the lung, whereas overexpression of wild-type SIPA1/
SPA1 limits metastasis (Park et al., 2005). Similarly, overexpression of
Rap1GAP increases invasion by regulating the metallo proteases 2 and
9 in squamous cell carcioma (Mitra et al., 2008). However, loss of
Rap1GAP expression has also been linked to an increased ability of
prostate cells, showing that cell type-speciﬁc contexts are important
(Bailey et al., 2009). This may not come as a surprise since multiple
pathways affect the cytoskeleton and integrin function in positive and
negative fashions and a ﬁne balance is most likely required for
metastasis. Finally, Rap1 may contribute to tumorigenesis by
enhancement of inﬂammation. This has been demonstrated in a
chemically induced skin-tumor model, where Rap1 acts via PLCɛ, a
Rap1 and Ras binding protein (Ikuta et al., 2008). Altogether, theseFig. 2. Overview of the Rap1 orthologs and their upstream and downstream acting proteins a
solely based on biochemical evidence, have not been included here.studies indicate that Rap1 affects proliferative and metastatic
properties of cancer cells. In addition, they support the notion that
research on the role of Rap1 in processes like migration and cell–cell
adhesion may contribute to a better understanding of tumorigenesis.
Concluding remarks and future prospects
Rap1 has been intensively studied during the last decade and
biochemical approaches have identiﬁed the major regulatory proteins
of Rap1. Genetic studies in model organisms have revealed a role for
Rap1 and its regulators in various morphogenetic processes via
establishment of polarity, regulation of adhesion/migration or cell–
cell contact formation. A major challenge is now to understand what
the molecular mechanisms are, that allow Rap1 to perform its diverse
functions. Remarkably, immediate downstream effectors of Rap1 that
have emerged so far from genetic studies differ for the various model
organisms (Fig. 2). In yeast a single effector, the CDC42-GEF CDC24, is
required for bud-site selection. In Dictyostelium, the non-conserved
kinase Phg2 affects cell adhesion and cell shape by acting on the
cytoskeleton. Cno functions downstream of Rap1 in various morpho-
genetic processes in Drosophila, but additional effectors must exist
that are required for e.g. ventral invagination. Rgl1 and D-raf have also
been put forward as Rap1 effectors in Drosophila. In mice, genetic
evidence supports a role for RapL downstream of Rap1 in integrin
activation in lymphocytes. Given that RapL expression is mostly
conﬁned to lymphocytes, further Rap1 effectors must play a similar
role in other cell types. Intriguingly, although many of these effectors
appear to act on the actin cytoskeleton, they do so in distinct manners.
For example, CDC24 activates CDC42, Phg-2 phosphorylates MyoII,
Cno may bind directly to actin and RapL associates with integrins and
may indirectly affect the cytoskeleton.
The myriad of proposed Rap1 effectors suggests an uncommon
versatile usage of this GTPase. It raises an immediate question about
the enormous ﬂexibility required during evolution to generate and
adapt to novel effectors. Or should we be more critical when
evaluating the presented data that have mostly been obtained in
reverse genetic studies and sometimes involve pleiotropic pheno-
types? We already indicated discrepancies in experiments with Dic-
tyostelium Phg-2 mutants. Complementary biochemical studies are
essential to provide solid evidence for an effector role of any given
protein. In this respect, more detailed information about the
interaction of Bud1 and CDC24 would be welcome. An equally
important question is how GTP-bound Rap1 changes the activity of
effectors like Phg2 and Cno, whose location is not affected by Rap1.
Ultimately, demonstrating a direct change in conformation, post-
translational modiﬁcation or protein complex formation for candidate
effectors upon stimulation of Rap1 is needed. This requires sophis-
ticated techniques, like novel mass spectrometry approaches and real
time imaging, to study in vivo changes of Rap1-associated proteins.
Compounds that act rapidly and speciﬁcally on a single GEF like 8-s supported by genetic evidence. Proteins, whose function in Rap1 signaling networks is
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point that should be kept in mind is that genetic studies largely
depend on similarities of phenotypes. This is relatively straightfor-
ward where proteins function to simply activate a downstream
signaling element as in the case of Ras and Raf. However, for proteins
like Rap1 whose function may be to localize rather than to drive a
biochemical process, the situation is more difﬁcult. In such cases, a
protein acts in parallel with other proteins whose diminished function
may or may not result in an identical phenotype. Indeed, the
phenotype of Bud1 mutants in yeast differs from that of most
CDC24 mutant. The studies on Cno in Drosophila where mutant
proteins are tested in a null background are a good example of how
genetics can contribute to a better understanding of the Rap1
signaling network. A similar detailed analysis of the Cno ortholog
Af6 in mice may reveal whether this protein functions as a Rap1
effector. Also a comparison of Af6 null mutant mice that die as
embryos with ultra-structurally abnormal cell–cell contacts and
polarization defects (Zhadanov et al., 1999) with early embryonic
lethal Rap1A/Rap1b double mutants (Chrzanowska-Wodnicka et al.,
2008) would be of interest.
In conclusion, the enigma of Rap1 and its many putative effectors
cannot be solved by genetics only. Genetics will however remain
crucial for validating outcomes from biochemical studies and
evaluating the suitability of Rap1 and its regulators as drug targets
in disease processes like thrombus formation and metastasis.Acknowledgments
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